China SXT Pharmaceuticals
SXTC
SXTC
6 hedge funds and large institutions have $1.58M invested in China SXT Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Hudson Bay Capital Management
Stamford,
Connecticut
| $1.2M | 2,149,187 | +149,187 | +7% |
|
2
Renaissance Technologies
New York
| $335K | 598,741 | +420,140 | +235% |
|
3
Citadel Advisors
Miami,
Florida
| $14K | 24,312 | +24,312 | New |
|
4
UBS Group
Zurich,
Switzerland
| $11K | 20,000 | +19,990 | +199,900% |
|
|
BWA
5
Beam Wealth Advisors
Covington,
Louisiana
| $10K | 17,000 | +4,000 | +31% |
|
6
Acadian Asset Management
Boston,
Massachusetts
| $10K | 17,367 | +17,367 | New |
|
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -9,071 | Closed |
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -295 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|